Volume 118, Issue 5 p. 1237-1245
Free Access

Characterization of a human 5-hydroxytryptamine3 receptor type A (h5-HT3R-AS) subunit stably expressed in HEK 293 cells

Anthony G. Hope

Anthony G. Hope

Neurosciences Institute, Department of Pharmacology and Clinical Pharmacology, Ninewells Hospital and Medical School, Dundee University, Dundee DD1 9SY, U.K.

Search for more papers by this author
John A. Peters

Corresponding Author

John A. Peters

Neurosciences Institute, Department of Pharmacology and Clinical Pharmacology, Ninewells Hospital and Medical School, Dundee University, Dundee DD1 9SY, U.K.

Neurosciences Institute, Department of Pharmacology and Clinical Pharmacology, Ninewells Hospital and Medical School, Dundee University, Dundee DD1 9SY, U.K.Search for more papers by this author
Angus M. Brown

Angus M. Brown

Neurosciences Institute, Department of Pharmacology and Clinical Pharmacology, Ninewells Hospital and Medical School, Dundee University, Dundee DD1 9SY, U.K.

Search for more papers by this author
Jeremy J. Lambert

Jeremy J. Lambert

Neurosciences Institute, Department of Pharmacology and Clinical Pharmacology, Ninewells Hospital and Medical School, Dundee University, Dundee DD1 9SY, U.K.

Search for more papers by this author
Thomas P. Blackburn

Thomas P. Blackburn

Psychiatry Research Department, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park (North), Third Avenue, Harlow, Essex CM19 5AW

Search for more papers by this author
First published: July 1996
Citations: 39

Abstract

  • 1

    A cloned cDNA encoding a human 5-hydroxytryptamine3 receptor type A subunit (h5-HT3R-AS) was transfected into human embryonic kidney (HEK 293) cells maintained in cell culture and a stable cell line expressing a high density of the recombinant receptor was selected.

  • 2

    Membrane homogenates prepared from transfected, but not untransfected, cells exhibited a homogeneous and saturable population (Bmax = 4.49 ± 0.46 pmol mg−1 protein) of sites that bound the radiolabelled 5-HT3 receptor antagonist, [3H]-granisetron with high affinity (pKD = 8.87 ± 0.08). Kinetic studies (at 37°C) revealed rapid association (k+1 = 4.76 ± 0.3 × 108 m−1 min−1) and dissociation (k-1 = 0.21 ± 0.003 min−1) of the radioligand.

  • 3

    Selective and non-selective 5-HT3 receptor ligands competed for [3H]-granisetron binding with a rank order of potency (granisetron > ondansetron > meta-chlorophenylbiguanide > 5-HT > 2-methyl-5-HT> metoclopramide >> phenylbiguanide > cocaine > (+)-tubocurarine) identical to that established for 5-HT3 receptors endogenous to the human CNS.

  • 4

    In electrophysiological recordings performed on transfected cells, voltage-clamped at a holding potential of −60 mV, locally applied 5-HT (10 μm) evoked transient inward current responses that reversed in sign at a potential of −1.0 ± 1.1 mV. Such responses were antagonized in a reversible manner by granisetron (1 nM).

  • 5

    The construction of a stable cell line expressing a high density of recombinant human 5-HT3 receptors which display appropriate pharmacology and function will assist in the further characterization of this receptor subtype and the exploration of species differences in 5-HT3 receptor pharmacology.